Author:
Zhang Xiumei,Tang Shilin,Huang Guohua,Xu Zhihong,Feng Caiju,Yan Gaowu,He Suyu
Abstract
AbstractHigh-intensity focused ultrasound (HIFU) has been reported to be a minimally invasive effective method for the treatment of secondary hypersplenism. However, neither the short-term efficacy nor the indications and/or contraindications have been described in patients with cirrhosis. From October 2019 to May 2021, eleven cases of patients with cirrhotic secondary hypersplenism were enrolled. The blood counts, liver function tests and abdominal ultrasound and/or MRI scans of all patients were closely evaluated. Among these 11 patients, eight (72.7%) patients were classified as Child–Pugh A, and the other 3 (27.3%) patients were Child–Pugh B; Five (45%) patients were diagnosed with gallstone, including multiple small stones in 2 patients and single stone in 3 patients. HIFU was performed successfully in all 11 patients. After HIFU, hematologic parameters and liver function were significantly improved in all 11 patients (p < 0.05). The HIFU ablated volume to spleen volume rate was 35–61%. Complications were ecchymosis of the waist in 7 (63.3%) patients, ablated area pain in 3 (27.3%) patients, and choledocholithiasis in 2 (18.2%) patients with multiple small gallstones. All of them recovered smoothly without additional treatment except for 2 patients with choledocholithiasis recovered with risky endoscopic retrograde cholangiopancreatography (ERCP) treatment. This series suggested that HIFU is an effective and safe treatment for cirrhotic secondary hypersplenism in patients classified as Child–Pugh A or B. However, multiple small gallstones could be a relative contraindication for it.
Publisher
Springer Science and Business Media LLC
Reference22 articles.
1. Talwar, A. et al. Adverse events related to partial splenic embolization for the treatment of hypersplenism: A systematic review. J. Vasc. Interv. Radiol. 31, 1118–1131 (2020).
2. Sun, X. et al. Partial splenic embolization combined with endoscopic therapies and NSBB decreases the variceal rebleeding rate in cirrhosis patients with hypersplenism: A multicenter randomized controlled trial. Hepatol. Int. 15, 741–752 (2021).
3. Duan, Y. Q. & Liang, P. Thermal ablation for partial splenectomy hemostasis, spleen trauma, splenic metastasis and hypersplenism. Hepatogastroenterology. 60, 501–506 (2013).
4. Izadifar, Z., Izadifar, Z., Chapman, D. & Babyn, P. An introduction to high intensity focused ultrasound: Systematic review on principles, devices, and clinical applications. J. Clin. Med. 9, 460 (2020).
5. Li, W., Jiang, Z., Deng, X. & Xu, D. Long-term follow-up outcome and reintervention analysis of ultrasound-guided high intensity focused ultrasound treatment for uterine fibroids. Int. J. Hyperthermia. 37, 1046–1051 (2020).